InsiderTrades

Form 4 for FCX Freeport-McMoRan

Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001214659-26-001508 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-02-11 2026-02-09 FCX Currault Douglas N. II EVP, GC F - Tax $60.67 -6,253 219.2K -3% -$379.4K
DM 2026-02-11 2026-02-11 FCX Currault Douglas N. II EVP, GC M - OptEx $11.90 +75.0K 244.2K +44% +$892.2K
D 2026-02-11 2026-02-11 FCX Currault Douglas N. II EVP, GC S - Sale+OE $64.52 -75.0K 219.2K -25% -$4.84M
DM 2026-02-11 2026-02-09 FCX Currault Douglas N. II EVP, GC A - Grant $0.00 +34.6K 204.8K +20% $0
DM 2026-02-11 2026-02-11 FCX Currault Douglas N. II EVP, GC M - OptEx $0.00 -75.0K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-02-09 F D 6,253 $60.67 219,181 D — —
2 Common Common Stock 2026-02-11 M A 50,000 $11.91 294,181 D — —
3 Common Common Stock 2026-02-11 M A 25,000 $11.87 244,181 D — —
4 Common Common Stock 2026-02-11 S D 75,000 $64.52 219,181 D — — (F5) The price reported represents the weighted average price of the shares sold. Shares were sold at varying prices in the range of $64.5100 - $64.5550. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. (F6) Amount beneficially owned includes 57,166 RSUs.
5 Common Common Stock 2026-02-09 A A 20,625 $0.00 225,434 D — —
6 Common Common Stock 2026-02-09 A A 14,000 $0.00 204,809 D — —
7 Derivative Options (Right to Buy) 2026-02-11 M D 50,000 $0.00 0 D $11.91 · 2020-02-06 to 2029-02-06 50,000 Common Stock (F4) 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof.
8 Derivative Options (Right to Buy) 2026-02-11 M D 25,000 $0.00 0 D $11.87 · 2020-02-05 to 2029-02-05 25,000 Common Stock (F4) 33% exercisable on the date indicated and 33% exercisable on each of the next two anniversaries thereof.